InTandem Capital Partners

InTandem Capital Partners is a private equity firm that invests in and helps accelerate the growth of small to mid-sized companies in select healthcare services sectors. Through an operationally intensive approach and utilizing an integrated operating team, the firm specializes in helping local leaders become national powerhouses. InTandem primarily targets companies with an EBITDA between $5 million and $30 million, though it also considers larger opportunities and smaller growth equity investments. The firm is committed to the healthcare 'Quintuple Aim,' focusing on enhanced patient experience, elevated provider experience, improved clinical outcomes, greater healthcare equity, and lower cost of care delivery. InTandem's team comprises former business executives and experienced investors, uniquely qualified to provide strategic, acquisition, and operating expertise to help companies significantly increase their value over time. The firm provides active support to the management of its portfolio companies directly and leverages its network of industry executives to augment its capabilities. InTandem's portfolio includes companies such as Cano Health, Paradigm Oral Health, Pediatric Home Service, Turning Point Centers, Ivy Fertility, and Providence Care. The firm has demonstrated a strong track record, closing its third fund in June 2024 with $715 million in total capital commitments, exceeding its original target of $650 million. This success reflects the depth and experience of the team and the firm's reputation built over two decades of partnering with healthcare services entrepreneurs. InTandem's approach is thematic, not opportunistic, seeking to build companies with the potential to redefine the way healthcare is delivered in America. The firm maintains a limited portfolio, enabling focused attention on the success of each company, and capitalizes its investments conservatively, avoiding aggressive financial leverage. InTandem's commitment to corporate and social responsibility is evident in its 'Private Equity for Greater Good' program, which aims to redefine employee equity ownership opportunities by enabling all full-time employees at InTandem-backed portfolio companies to share in the equity gains they help create. This initiative reflects the firm's belief that success should be shared with all who contribute to it, proportional to their tenure, particularly against the backdrop of growing income and wealth inequality and the societal inequities that they create. InTandem's unique blend of operating and investment experience has positively impacted its values and culture, fostering a team that values honesty, hard work, great insight, relentless energy, a sense of humor, and a fun-loving spirit. The firm's track record is characterized by recurring engagements and partnerships with executives who share these values, forming an extensive network of support for its portfolio companies. InTandem's investment strategy is flexible in terms of deal size and structure, targeting companies with an EBITDA between $5 million and $30 million but also considering larger opportunities and smaller growth equity investments. The firm is committed to the healthcare 'Quintuple Aim,' focusing on enhanced patient experience, elevated provider experience, improved clinical outcomes, greater healthcare equity, and lower cost of care delivery. InTandem's team comprises former business executives and experienced investors, uniquely qualified to provide strategic, acquisition, and operating expertise to help companies significantly increase their value over time. The firm provides active support to the management of its portfolio companies directly and leverages its network of industry executives to augment its capabilities. InTandem's portfolio includes companies such as Cano Health, Paradigm Oral Health, Pediatric Home Service, Turning Point Centers, Ivy Fertility, and Providence Care. The firm has demonstrated a strong track record, closing its third fund in June 2024 with $715 million in total capital commitments, exceeding its original target of $650 million. This success reflects the depth and experience of the team and the firm's reputation built over two decades of partnering with healthcare services entrepreneurs. InTandem's approach is thematic, not opportunistic, seeking to build companies with the potential to redefine the way healthcare is delivered in America. The firm maintains a limited portfolio, enabling focused attention on the success of each company, and capitalizes its investments conservatively, avoiding aggressive financial leverage. InTandem's commitment to corporate and social responsibility is evident in its 'Private Equity for Greater Good' program, which aims to redefine employee equity ownership opportunities by enabling all full-time employees at InTandem-backed portfolio companies to share in the equity gains they help create. This initiative reflects the firm's belief that success should